SUVRETTA CAPITAL MANAGEMENT, LLC 13D and 13G filings for ArriVent BioPharma, Inc. Common Stock:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-12-04 4:32 pm Purchase |
2024-11-26 | 13G | ArriVent BioPharma, Inc. Common Stock AVBP |
SUVRETTA CAPITAL MANAGEMENT, LLC | 2,040,365 6.100% |
2,040,365 (New Position) |
Filing |